OrthoPediatrics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KIDS and other ETFs, options, and stocks.

About KIDS

OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. It offers products relating to trauma and deformity, scoliosis, and sports medicine and other procedures. 

CEO
David R. Bailey
CEODavid R. Bailey
Employees
602
Employees602
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
2006
Founded2006
Employees
602
Employees602

KIDS Key Statistics

Market cap
447.05M
Market cap447.05M
Price-Earnings ratio
-10.18
Price-Earnings ratio-10.18
Dividend yield
Dividend yield
Average volume
221.30K
Average volume221.30K
High today
$17.44
High today$17.44
Low today
$17.25
Low today$17.25
Open price
$17.27
Open price$17.27
Volume
6.63K
Volume6.63K
52 Week high
$23.70
52 Week high$23.70
52 Week low
$14.42
52 Week low$14.42

Stock Snapshot

The current OrthoPediatrics(KIDS) stock price is $17.41, with a market capitalization of 447.05M. The stock trades at a price-to-earnings (P/E) ratio of -10.18.

As of 2026-05-07, OrthoPediatrics(KIDS) stock has fluctuated between $17.25 and $17.44. The current price stands at $17.41, placing the stock +0.9% above today's low and -0.2% off the high.

OrthoPediatrics(KIDS) shares are trading with a volume of 6.63K, against a daily average of 221.3K.

In the last year, OrthoPediatrics(KIDS) shares hit a 52-week high of $23.70 and a 52-week low of $14.42.

In the last year, OrthoPediatrics(KIDS) shares hit a 52-week high of $23.70 and a 52-week low of $14.42.

KIDS News

TipRanks 6d
OrthoPediatrics price target lowered to $17 from $20 at Truist

Truist lowered the firm’s price target on OrthoPediatrics (KIDS) to $17 from $20 and keeps a Hold rating on the shares. The firm notes that sales upside relativ...

TipRanks 6d
Analyst Reiterates Buy on OrthoPediatrics, Maintains $23 Price Target on Strong Q1 Beat and Raised Sales Guidance

OrthoPediatrics, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Mathew Blackman from TD Cowen maintained a Buy rating...

Nasdaq 7d
OrthoPediatrics Q1 2026 Earnings Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

OrthoPediatrics Q1 2026 Earnings Transcript

Analyst ratings

89%

of 9 ratings
Buy
88.9%
Hold
11.1%
Sell
0%

More KIDS News

TipRanks 7d
OrthoPediatrics reports Q1 EPS (42c), consensus (48c)

Reports Q1 revenue $59.36M, consensus $58.32M. David Bailey, President & CEO of OrthoPediatrics (KIDS), commented, “We delivered a strong start to 2026 with 13%...

People also own

Based on the portfolios of people who own KIDS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.